REG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
Today 14:30
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260518:nRSR7696Ea&default-theme=true
RNS Number : 7696E Barclays PLC 18 May 2026
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose ADVANCED MEDICAL SOLUTIONS GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 15 May 2026
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: 5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 719,921 0.33% 1,363,908 0.62%
(2) Cash-settled derivatives:
1,314,974 0.60% 719,694 0.33%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 2,034,895 0.92% 2,083,602 0.95%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
5p ordinary Purchase 103,578 2.4700 GBP
5p ordinary Purchase 39,691 2.4876 GBP
5p ordinary Purchase 21,616 2.4773 GBP
5p ordinary Purchase 17,105 2.4641 GBP
5p ordinary Purchase 8,751 2.4796 GBP
5p ordinary Purchase 7,124 2.4805 GBP
5p ordinary Purchase 5,507 2.4800 GBP
5p ordinary Purchase 4,054 2.4739 GBP
5p ordinary Purchase 2,313 2.4836 GBP
5p ordinary Purchase 2,306 2.4699 GBP
5p ordinary Purchase 2,169 2.4799 GBP
5p ordinary Sale 144,636 2.5250 GBP
5p ordinary Sale 66,124 2.4700 GBP
5p ordinary Sale 30,943 2.4733 GBP
5p ordinary Sale 17,281 2.4838 GBP
5p ordinary Sale 10,000 2.4799 GBP
5p ordinary Sale 6,044 2.4825 GBP
5p ordinary Sale 5,000 2.5424 GBP
5p ordinary Sale 3,837 2.5171 GBP
5p ordinary Sale 1,355 2.4834 GBP
5p ordinary Sale 1,132 2.4862 GBP
5p ordinary Sale 429 2.4723 GBP
5p ordinary Sale 96 2.4850 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
5p ordinary SWAP Increasing Long 6,759 2.4698 GBP
5p ordinary SWAP Increasing Long 1,770 2.4700 GBP
5p ordinary SWAP Increasing Long 429 2.4723 GBP
5p ordinary SWAP Increasing Long 30,943 2.4733 GBP
5p ordinary SWAP Increasing Long 3,828 2.4783 GBP
5p ordinary SWAP Increasing Long 1,276 2.4893 GBP
5p ordinary SWAP Increasing Long 3,794 2.5123 GBP
5p ordinary SWAP Increasing Long 3,837 2.5171 GBP
5p ordinary SWAP Increasing Long 144,636 2.5250 GBP
5p ordinary SWAP Increasing Long 200 2.5399 GBP
5p ordinary SWAP Decreasing Long 31,142 2.4700 GBP
5p ordinary SWAP Decreasing Long 8,071 2.4704 GBP
5p ordinary SWAP Decreasing Long 4,054 2.4739 GBP
5p ordinary SWAP Decreasing Long 8,751 2.4796 GBP
5p ordinary SWAP Decreasing Long 11,947 2.4829 GBP
5p ordinary SWAP Decreasing Long 15,093 2.4833 GBP
5p ordinary SWAP Decreasing Long 2,313 2.4836 GBP
5p ordinary SWAP Decreasing Long 800 2.4851 GBP
5p ordinary SWAP Decreasing Long 12,356 2.4971 GBP
5p ordinary CFD Increasing Long 39,879 2.4700 GBP
5p ordinary CFD Increasing Long 5,755 2.4807 GBP
5p ordinary CFD Decreasing Long 71,645 2.4700 GBP
5p ordinary CFD Decreasing Long 2,899 2.5202 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercise
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 18 May 2026
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETGZGMKFRKGVZM
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Barclays
See all newsREG - Barclays PLC Tate & Lyle PLC - Form 8.3 TATE & LYLE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC AMG Critical N.V. - Form 8.3 - AMG LITHIUM B.V.
AnnouncementREG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
Announcement